Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia
Rodrigo A. Toledo(Instituto de Salud Carlos III), Patricia L. M. Dahia(The University of Texas at San Antonio Health Science Center), Camilo Jiménez(The University of Texas MD Anderson Cancer Center), Gustavo Armaiz-Peña(The University of Texas at San Antonio Health Science Center), Carlota Arenillas(Universitat Autònoma de Barcelona), Jaume Capdevila(Vall d'Hebron Hospital Universitari)
Cited by 86
Related Papers
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
|Annals of Oncology|2015|698
PTEN, a unique tumor suppressor gene.
|Endocrine Related Cancer|2000|285
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
|Journal of Diabetes Science and Technology|2022|272
American Association of Endocrine Surgeons Guidelines for Adrenalectomy
|JAMA Surgery|2022|224